Quantum Image Processing (QIP) is a field that aims to utilize the benefits of quantum computing for manipulating and analyzing images. However, QIP faces two challenges: the limitation of qubits and the presence of noise in a quantum machine. In this research we propose a novel approach to address the issue of noise in QIP. By training and employing a machine learning model that identifies and corrects the noise in quantum processed images, we can compensate for the noisiness caused by the machine and retrieve a processing result similar to that performed by a classical computer with higher efficiency. The model is trained by learning a dataset consisting of both existing processed images and quantum processed images from open access datasets. This model will be capable of providing us with the confidence level for each pixel and its potential original value. To assess the model's accuracy in compensating for loss and decoherence in QIP, we evaluate it using three metrics: Peak Signal to Noise Ratio (PSNR), Structural Similarity Index (SSIM), and Mean Opinion Score (MOS). Additionally, we discuss the applicability of our model across domains well as its cost effectiveness compared to alternative methods.
The Research & Development (R&D) phase of drug development is a lengthy and costly process. To revolutionize this process, we introduce our new concept QMLS to shorten the whole R&D phase to three to six months and decrease the cost to merely fifty to eighty thousand USD. For Hit Generation, Machine Learning Molecule Generation (MLMG) generates possible hits according to the molecular structure of the target protein while the Quantum Simulation (QS) filters molecules from the primary essay based on the reaction and binding effectiveness with the target protein. Then, For Lead Optimization, the resultant molecules generated and filtered from MLMG and QS are compared, and molecules that appear as a result of both processes will be made into dozens of molecular variations through Machine Learning Molecule Variation (MLMV), while others will only be made into a few variations. Lastly, all optimized molecules would undergo multiple rounds of QS filtering with a high standard for reaction effectiveness and safety, creating a few dozen pre-clinical-trail-ready drugs. This paper is based on our first paper, where we pitched the concept of machine learning combined with quantum simulations. In this paper we will go over the detailed design and framework of QMLS, including MLMG, MLMV, and QS.